The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

Explore 5 major types of food safety issues that the FDA routinely monitors, including foodborne pathogens and food fraud.

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

For much of its 15-year history, supplement brand AG1 refused to sell through Amazon, preferring its own site. That changed ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Almost all of the packaged food and drink sold in Kenya by local and international companies would require a health warning ...

U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...